Coherus Oncology, Inc. (CHRS)
1.41
-0.05
(-3.42%)
USD |
NASDAQ |
Aug 28, 16:00
1.40
-0.01
(-0.71%)
After-Hours: 20:00
Coherus Oncology Price : 1.41 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 1.45 | 1.48 | 1.40 | 1.41 | 605088.0 |
| Aug 27, 2026 | 1.43 | 1.48 | 1.41 | 1.46 | 788317.0 |
| Aug 26, 2026 | 1.37 | 1.455 | 1.34 | 1.45 | 896541.0 |
| Aug 25, 2026 | 1.36 | 1.410 | 1.31 | 1.37 | 1.297M |
| Aug 24, 2026 | 1.43 | 1.43 | 1.35 | 1.36 | 1.046M |
| Aug 21, 2026 | 1.32 | 1.44 | 1.315 | 1.42 | 1.568M |
| Aug 20, 2026 | 1.31 | 1.34 | 1.27 | 1.32 | 740186.0 |
| Aug 19, 2026 | 1.379 | 1.405 | 1.295 | 1.33 | 3.038M |
| Aug 18, 2026 | 1.26 | 1.36 | 1.22 | 1.34 | 3.478M |
| Aug 17, 2026 | 1.20 | 1.200 | 1.13 | 1.15 | 1.265M |
| Aug 14, 2026 | 1.16 | 1.205 | 1.14 | 1.20 | 648327.0 |
| Aug 13, 2026 | 1.18 | 1.195 | 1.13 | 1.14 | 1.060M |
| Aug 12, 2026 | 1.21 | 1.246 | 1.17 | 1.17 | 1.156M |
| Aug 11, 2026 | 1.25 | 1.260 | 1.18 | 1.21 | 968344.0 |
| Aug 10, 2026 | 1.33 | 1.34 | 1.23 | 1.24 | 978461.0 |
| Aug 07, 2026 | 1.27 | 1.40 | 1.24 | 1.27 | 1.600M |
| Aug 06, 2026 | 1.385 | 1.455 | 1.131 | 1.265 | 3.722M |
| Aug 05, 2026 | 1.48 | 1.525 | 1.435 | 1.45 | 999321.0 |
| Aug 04, 2026 | 1.43 | 1.50 | 1.43 | 1.48 | 617715.0 |
| Aug 03, 2026 | 1.42 | 1.459 | 1.414 | 1.44 | 477295.0 |
| Jul 31, 2026 | 1.48 | 1.48 | 1.40 | 1.41 | 437184.0 |
| Jul 30, 2026 | 1.42 | 1.485 | 1.415 | 1.47 | 509553.0 |
| Jul 29, 2026 | 1.449 | 1.475 | 1.40 | 1.41 | 570978.0 |
| Jul 28, 2026 | 1.46 | 1.47 | 1.415 | 1.44 | 387626.0 |
| Jul 27, 2026 | 1.46 | 1.495 | 1.44 | 1.46 | 456657.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enanta Pharmaceuticals, Inc. | 13.60 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |
| Anika Therapeutics, Inc. | 21.10 |
| Savara, Inc. | 5.26 |
Price Related Metrics
| PS Ratio | 3.653 |
| Price to Book Value | 3.58 |
| Earnings Yield | -72.43% |
| Market Cap | 217.80M |